top of page
$2.45
+0.05 (+2.08%)
chg neg
quotes and stock data may be delayed 15 minutes
My Notes
Only BPIQ Pro members can create company notes. Learn more here.
52 wk low
2.34
52 wk hi
14.22
Cash
$263.5M
Burn Rate (Qtr)
$16.6M
Mkt Cap
$93.0m
Avg Volume
278,476
*cash/burn updated:
Q1 '22
Drug Pipeline
Click the button to see the updated pipeline
No drug found
We don't have any drug data for this company yet
Drug | Disease (links)
Stage (next event)
Catalyst Date
Loading Catalysts...
search in progress
Pipeline powered by
ATHA
Company Profile
At Athira, we aim to restore neuronal health for those suffering from neurological diseases, including Alzheimer’s, so that patients can regain their memories, lives, and family relationships.
Recent Posts
See what the community is saying - click to see full post.
bottom of page